scispace - formally typeset
N

Neal R. Cutler

Researcher at National Institutes of Health

Publications -  183
Citations -  7124

Neal R. Cutler is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Placebo & Tolerability. The author has an hindex of 41, co-authored 183 publications receiving 6879 citations. Previous affiliations of Neal R. Cutler include University of Utah & University of Virginia.

Papers
More filters
Journal ArticleDOI

Positron emission tomography in Alzheimer's disease

TL;DR: PET is useful in quantifying regional cerebral dysfunction in DAT, even in the early stages of the disease, and reduces in ratio measures of relative metabolism in some parietal, temporal, and frontal regions were found.
Journal ArticleDOI

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

TL;DR: The observed improvements in ADAS-Cog and CIBIC+ following treatment with xanomeline provide the first evidence, from a large-scale, placebo-controlled clinical trial, that a direct-acting muscarinic receptor agonist can improve cognitive function in patients with AD.
Journal ArticleDOI

Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease

TL;DR: The results demonstrate that discrepancies between language and visuospatial deficits in patients with early AD are related to asymmetrical reductions in cerebral cortical glucose metabolism.
Journal ArticleDOI

Human brain glucose utilization and cognitive function in relation to age

TL;DR: The results indicate that brain oxidative metabolism, when measured under resting conditions with reduced sensory input, is not reduced in relation to age in healthy men and no significant relations between intelligence and resting cerebral metabolism are evident.